Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Carpal Arch Space Augmentation (CASA) Clinical Trial

NCT06208709 · View on ClinicalTrials.gov ↗

Study Summary

This research proposes to evaluate the effectiveness of a novel device designed for the treatment of carpal tunnel syndrome. The device applies a small cyclic force to the wrist. The cycles include a small time period of force is applied, followed by a brief period of no force. The device is intended to be worn during hours of sleep. The efficacy of the treatment is evaluated based on patient reported outcomes. Treatment efficacy will also be evaluated based on comparisons to patient reported outcomes for a SOC treatment.

Conditions Studied

Interventions

  • DEVICE carpal arch space augmentation (CASA)
  • DEVICE standard of care (SOC)

Study Locations (1)

Arizona

  • University of Arizona — Tucson

Trial Details

FieldValue
Enrollment Target 116 participants
Start Date 2024-04-23
Est. Completion 2026-07-31
Phase NA

Sponsor

University of Arizona

379 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06208709

The ClinicalTrials.gov registry entry for NCT06208709 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Arizona, which has 379 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 2 interventions — of which carpal arch space augmentation (CASA) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06208709 reports 1 study location spanning 1 distinct geographic area — top geographies include Arizona. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06208709 about?

NCT06208709 is a clinical study titled "Carpal Arch Space Augmentation (CASA) Clinical Trial". This research proposes to evaluate the effectiveness of a novel device designed for the treatment of carpal tunnel syndrome. The device applies a small cyclic force to the wrist. The cycles include a small time period of force is applied, followed by a brief period of no force. The device is intende...

What is the current status of trial NCT06208709?

This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2024-04-23. Estimated completion is 2026-07-31.

What conditions does trial NCT06208709 study?

This clinical trial studies the following conditions: Carpal Tunnel Syndrome. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06208709?

The interventions under investigation include: carpal arch space augmentation (CASA) (DEVICE), standard of care (SOC) (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06208709?

This trial is sponsored by University of Arizona, which has 379 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06208709 being conducted?

This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial